Where do MoonLake Immunotherapeutics's ratios come from?

Every ratio is computed from MoonLake Immunotherapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Returns
Return on equity	-60.5%-35.3pp	-25.2%-12.0pp	-13.2%—	——
Return on assets	-50.4%-26.7pp	-23.7%-11.7pp	-11.9%+116pp	-127.6%+19.1pp
Return on invested capital	-155.5%-65.3pp	-90.2%+96.9pp	-187%—	——
Liquidity
Current ratio	9.3×-11.8×	21.1×-30.5×	51.6×+41.6×	10×+9.5×
Quick ratio	9.3×-11.8×	21.1×-30.5×	51.6×+41.6×	10×+9.5×
Cash ratio	7.4×-0.7×	8×-37.2×	45.3×+40.1×	5.2×+4.8×
Leverage
Debt-to-equity	0.2×+0.2×	0×0.0×	0×0.0×	0×—
Debt-to-assets	0.2×+0.2×	0×0.0×	0×0.0×	0×-1.6×
Interest coverage	-33.8×—	——	——	——
Per Share
Book value per share	$4.72-33.5%	$7.11-29.6%	$10.09+506%	$1.67+212%
Valuation
Market capitalization	$933.77M-72.7%	$3.41B-5.6%	$3.62B+787%	$407.86M+11.7%
Enterprise value	$674.96M-79.2%	$3.24B+2.1%	$3.17B+760%	$368.64M-1.1%
Price / book	3.1×-4.6×	7.6×+0.3×	7.3×-1.0×	8.3×—
Free cash flow yield	-21%-17.6pp	-3.4%-2.2pp	-1.2%+12.5pp	-13.7%—
Earnings yield	-24.3%-20.9pp	-3.5%-2.5pp	-1%+12.5pp	-13.5%+11.8pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do MoonLake Immunotherapeutics's ratios come from?: Every ratio is computed from MoonLake Immunotherapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.